and 12 asa.johansson@igp.uu.se 13 14 15 16 17 18 Body mass and body fat composition are of clinical interest due to their links to 19
overweight 2 and 10.8% are obese 3 . Obesity is set to become the world's leading 37 preventable risk factor for disease and early death due to the increased risks of 38 developing type 2 diabetes, cardiovascular disease, and cancer 4 . 39
40
The distribution of adipose tissue to discrete compartments within the human body is 41 associated with differential risk for development of cardiovascular and metabolic 42 disease 5 . Body fat distribution of fat is also well known to differ between sexes. After 43 puberty, women accumulate fat in the trunk and limbs to a proportionally greater 44 extent compared to other parts of the body, while men accumulate a greater extent of 45 fat in the trunk 6 . Accumulation of adipose tissue around the viscera, the internal 46 organs of the body, has been shown to be associated with increased risk of disease in 3 both men and women 7 . In contrast, the preferential accumulation of adipose tissue in 48 the lower extremities, i.e. the hips and legs, has been suggested as a factor 49 contributing to the lower incidence of myocardial infarction and coronary death 50 observed in women during middle age 8 . The differential distribution of body fat 51 between sexes has been attributed to downstream effects of sex hormone secretion 5 . 52 However, the biological mechanisms that underlie body fat distribution have not been 53 fully elucidated. 54 55 BMI is commonly used as a proxy measurement of body adiposity in epidemiological 56 studies and in clinical practice. However, BMI is unable to discriminate between 57 adipose and lean mass, and between fat stored in different compartments of the body. 58
Other proxies that better represent distribution of body fat have also been utilized, 59 such as the waist-to-hip ratio (WHR), waist circumference (WC), and hip 60 circumference (HC). Through genome-wide association studies (GWAS), researchers 61 proportion of body fat located in the trunk compared to females (62.2% vs. 50.3%) 98 and women had a larger proportion of body fat located in the legs (39.7% vs. 28.1%). 99
While the total amount of adipose tissue in the arms was estimated to be higher in 100 women compared to men, the fraction of adipose tissue distributed to the arms were 101 similar. Several smaller differences between the discovery and replication cohorts 102 were present (supplementary Table 1 ), such as some slight differences in height and 103 age between men and women in the discovery and replication cohorts. These 104 differences most likely represent the 50,000 participants for the UK Biobank Lung 105 Exome Variant Evaluation (UK BiLEVE) project that were included in the first 106 release of genotyping data for ~150,000 participants, which were used as a discovery 107 cohort in this study. Selection for UK BiLEVE was conducted with specific 108 consideration to lung function which may reflect the differences in baseline 109 characteristics for this subset of the cohort. However, these differences are unlikely to 110 affect the results from our analyses. 111 112 Genome wide association study for body fat ratio 113 GWAS was performed for each of the three phenotypes (AFR, LFR and TFR) in the 114 whole discovery cohort (sex-combined) and when stratifying by sex (males and 115 females), adjusting for covariates as described in the method section. A total of 116 25,472,837 imputed SNPs, with MAF of at least 0.0001, were analyzed in the 117 discovery GWAS. LD score regression intercepts 17 ranged from 1.00 to 1.03 118 (supplementary Figure 1, supplementary Table 2) , and were used to adjust for 119 genomic inflation. We used the -clump function in PLINK 18 , in combination with 120 conditioning on the most significant SNP, to identify associations that were 121 independent within each GWAS as well as between GWAS for the three body fat 6 ratios (AFR, TFR, or LFR) or strata (males, females or sex-combined) (see methods). 123
In total, 133 independent associations at 114 loci were observed in the discovery 124 analyses (Figure 1c , Supplementary Figure 2 -4, Supplementary Data 1). For each of 125 the independent associations, the leading SNP (the SNP that was most significant in 126 any of the phenotypes or strata) was taken forward for replication. In total, 97 of the 127 133 independent associations (Supplementary Data 1) replicated (P<0.05/133). Out of 128 these, 30 were associated with AFR, 42 with LFR and 65 with TFR in either the sex-129 combined or sex-stratified analyses. There was substantial overlap in associated loci 130 between LFR and TFR loci ( Figure 2 ) while associations with AFR overlapped to a 131 small degree. One locus in the vicinity of ADAMTSL3 was associated with all three 132 phenotypes. 133
134
In the sex-stratified GWAS, only six loci were associated (replication P-value < 135 0.05/133) with body fat ratios in males while 71 loci were observed in females. Sex-136 heterogenous effects of associated variants were tested for using the GWAMA 137 software. We observed 42 independent body fat ratio-associated variants whose effect 138 differed between females and males (P < 5.15*10 -4 , Table 2 ). In all but two cases, the 139 effects were stronger, or only present in females. Stronger effects in males were 140 observed for two AFR-associated variants rs3812049 near SLC12A2, and rs11289753 141 near PLCE1 (Table 2) . 142 143 LD score regression (LDSC) was used to estimate the fraction of variance of body fat 144 ratios that could be explained by SNPs, i.e. the SNP heritability 17 . SNP heritability 145 was higher in females compared to males for all traits and ranged from ~20% to 146 ~26% in females and from 12% to 16% in males (supplementary Table 2 ).
148
Phenotypic and genetic correlation between body fat ratios and anthropometric 149 phenotypes 150
Phenotypic correlations were assessed, in males and females separately, by 151 calculating squared semi-partial correlation coefficients from the ANOVA table of 152 two nested linear models that were adjusted for age and principal components, while 153 genetic correlations were estimated using cross-trait LD score regression 19 (see 154 methods). Overall, the genetic and phenotypic correlations showed a large degree of 155 similarity (supplementary Table 3 and 4) and the correlation between the 156 anthropometric traits and the ratios were in the same direction for phenotypic and 157 genetic correlations for all correlations that reached the threshold for significance. In 158 females, BMI and WC was strongly correlated with AFR both with regards to 159 phenotypic (BMI -78.9% and WC -54.3%; squared semi-partial correlation 160 coefficients, see supplementary Table 3 ) and genetic (BMI -79.2% and WC -51,8%; 161 squared genetic correlation coefficients, see supplementary Table 4) 
correlations. 162
Height also contributed to a moderate degree in explaining the phenotypic variance in 163 LFR and TFR in females (16.0% and 25.3%) even though the genotypic correlation 164 between height and both LFR and TFR was even higher (42.3% and 60.8% variance 165 explained). In males, anthropometric traits contributed only to a small degree, up to 166 4.8%, in explaining the phenotypic variance in the ratios. This is also supported by the 167 lower genetic correlations between these traits with the highest correlation seen 168 between BMI and TFR (14.4% variance explained). 169
170
There was also a strong correlation between LFR and TFR in both males and females 171 (>82% of the variance explained in both males and females and for both genetic and phenotypic correlations, supplementary Table 3 and 4). LFR and TFR were inversely 173 correlated, which agrees well with the large overlap in GWAS results for these 174 phenotypes and the fact that the effect estimates from the GWAS was in the opposite 175 direction for LFR and TFR (Supplementary Data 1). In contrast, AFR appeared to be 176 more independent as only a low amount of phenotypic and genetic correlation was 177 observed between AFR and the other two traits (supplementary Table 3 and 4). 178
179
Overlap with findings from previous GWAS 180 Body fat ratio-associated SNPs were tested for overlap with associations from 181 previous GWAS for anthropometric traits by determining LD with entries from 182 GWAS-catalog 20 . We used a strict cut-off of R 2 < 0.1 to distinguish novel findings. In 183 total, we identify 40 body fat ratio-associated signals that have not previously been 184 associated with an anthropometric trait (Table 1) . Forty body fat ratio associated 185 signals overlapped with previously identified height-associated loci 21,22 186 (Supplementary Data 1) and the majority of these signals were associated with TFR 187 and/or LFR (36 out of 40). For AFR, the strongest associations were observed at well-188 known BMI and adiposity-associated loci such as: FTO, MC4R, TMEM18, SEC16B 189 and TFAP2B (Supplementary Data 1), which agrees with the strong correlations 190 (genotypic and phenotypic) between AFR and BMI. 191
192
We also compared the direction of the effects for overlapping GWAS results by 193 estimating the effects of leading body fat ratio-associated SNPs on the respective 194 overlapping anthropometric traits in the discovery cohort. The effects of TFR-195 associated SNPs were directionally consistent with effects on height and 196 for AFR-associated SNPs were consistent with effects on BMI-, WC-and WHR 198 (supplementary Table 5 ), which agrees with the strong genetic and phenotypic 199 correlation between AFR and these phenotypes. 200 201 Among the novel loci, five overlapped with traits associated with cardiovascular 202 disease: two loci near ANKDD1B and KAT8 that have been associated with LDL 203 cholesterol 23 and triglycerides 24 , respectively; and three loci near KCNH2, XKR6 and 204 BMP2 that have been associated with QT interval 25-27 , thickness of the carotid intima 205 media 28 and QRS complex 29 , respectively (supplementary Table 6 ). 206 207 208
Functional annotation of associated loci 209
Functional annotation of the GWAS loci was performed by identifying overlap with 210 eQTLs from the Genotype-Tissue Expression (GTEx) project 30 and by identifying 211 potentially deleterious missense variants in LD (R 2 > 0.8) with our leading SNPs (see 212 method section). In total, 31 body fat ratio-associated loci overlapped with an eQTL 213 (Supplementary Data 2), and 11 leading SNPs were in LD with a potentially 214 deleterious missense variant ( Table 3 ). The probability for functional effects of 215 missense variants has been predicted by sequence analyses 31,32 and Polyphen and 216 SIFT-scores were used to assess the deleteriousness of the variants. Plausible causal 217 missense variants were found in ACAN, ADAMTS17, FGFR4 and ADAMTS10, where 218 the leading SNPs were predicted to have functional effects (Table 3) . Rs315855, 219
within FGFR4, has also previously been shown to be associated with progression of 220 cancer 33,34 and to affect insulin secretion in vitro 35 . 221
Enrichment analyses 223
To identify the functional roles and tissue specificity of associated variants, we 224 performed enrichment analyses with DEPICT (Data-driven Expression Prioritized 225
Integration for Complex Traits 36 , see method section). In these analyses we used 226 summary statistics from sex-stratified GWAS on the combined cohort (195,043 227 women and 167,408 men) in order to maximize statistical power. Enrichment was 228 only detected for TFR-and LFR-associated genes in females as well as LFR-229 associated genes in males (supplementary Data 3). We identified 212 enriched gene 230 sets and there was a substantial overlap of enriched gene sets between TFR-and LFR-231 in females as well as moderate overlap with LFR-associated gene sets in males 232 (supplementary Figure 5 ). The large fraction of overlapping gene sets between LFR 233 and TFR in females agrees well with the large overlap in GWAS signals. Gene sets 234 related to bone morphology and skeletal development (abnormal skeleton 235 morphology, short limbs, decreased length of long bones, skeletal system 236 morphogenesis) were among the most strongly associated with both LFR and TFR. 237
We also find the 'TGFβ signaling pathway' gene set to be enriched for genes within 238 the TFR and LFR-associated loci in females, as well as TGFβ downstream mediators: 239 'SMAD1-', 'SMAD2-', 'SMAD3-' and 'SMAD7 protein-protein interaction 240 subnetworks' (supplementary Data 3). 241
242
The results from enrichment analyses were compared with results from previous 243 GWAS for height 21 , BMI 9 and WHRadjBMI 12 . Gene-sets that were enriched for LFR 244 and TFR-associated genes were compared to results from previous GWAS for 245 height 21 , BMI 9 and WHRadjBMI 12 . Substantial overlap of enriched gene sets was 246 observed between LFR/TFR-with height and WHRadjBMI (Figure 3a ). In contrast, BMI associated biological processes overlapped only to a marginal extent: 2% of all 248 gene sets that enriched for BMI-associated genes were also enriched for LFR-and 249 TFR-associated genes. 250 In this study, we performed GWAS on distribution of body fat to different 260 compartments of the human body and identified and replicated 97 independent 261 associations of which 40 have not been associated with any adiposity related 262 phenotype previously. In contrast to previous studies, we have not addressed the total 263 amount of fat but rather the fraction of the total body fat mass that is located in the 264 arms, legs and trunk. Body fat distribution is well-known to differ between males and 265 females, which we also clearly show in our study. We also show that the genetic 266 effects that influence fat distribution are stronger in females compared to males. 267
These results are consistent with previous GWAS that have revealed sexual 268 dimorphisms in genetic loci for adiposity-related phenotypes, such as waist-269 circumference and waist-to-hip ratio 10,37,38 . Phenotypic and genetic correlations, as 270 well as results from GWAS and subsequent enrichment analyses, also revealed that 271 the amount of fat stored in the arms in females is highly correlated with BMI and WC.
This suggests that the proportion of fat stored in the arms will generally increase with 273 increased accumulation of body mass and adipose tissue. In contrast, males exhibited 274 moderate-to weak phenotypic and genetic correlations between the distribution of fat 275 to different parts of the body and anthropometric traits, which indicates that the 276 proportions of body fat mass in different compartments of the male body remains 277 more stable as body mass and body adiposity increases. Among the three phenotypes 278 analyzed in this study LFR and TFR were inversely correlated in both males and 279 females. This suggests that LFR and TFR to a large extent describe one trait, i.e. the 280 distribution of adipose tissue between these two compartments which is further 281 supported by the large overlap in GWAS loci between the two phenotypes. In 282 contrast, AFR was only weakly correlated with the other two traits. 283 284 Tissue enrichment revealed an important role in body fat distribution in females for 285 mesenchyme derived tissues: i.e. adipose and musculoskeletal tissues; as well as 286 tissues related to female reproduction. This suggests that the distribution of fat to the 287 legs and trunk in females is mainly driven by the effect of female gonadal hormones 288 on mesenchymal progenitors of musculoskeletal and adipose tissues. Enrichment 289 analyses also showed that LFR and TFR have unique features that separates them 290 from other anthropometric measurements, which was indicated by the portion of 291 LFR/TFR-associated gene sets that did not overlap with height-, BMI or 292
WHRadjBMI-associated gene sets. However, there was also an overlap in the 293 functional aspects between these traits with both height and WHRadjBMI. This is 294 indicated by the tissue enrichment profile for LFR/TFR-associated genes, which 295 shares features with tissue enrichments reported for height in previous GWAS 39 : 296 height-associated genes were strongly enriched in musculoskeletal tissue types with additional enrichment in cardiovascular and endocrine tissue types; as well as 298 WHRadjBMI 12 : associated genes were enriched in adipocytes and adipose tissue 299 subtypes. Of particular note, we did not identify any enrichment of body fat ratio-300 associated genes in CNS tissue gene sets in contrasts to enrichment analyses in 301 previous GWAS for BMI where CNS have been indicated to play a prominent role in 302 obesity susceptibility 9 . 303 304 In the GWAS for LFR and TFR in females, we find that several genes that highlight 305 the influence of biological processes related to the interaction between cells and the 306 extracellular matrix (ECM), as well as ECM-maintenance and remodeling. These 307 include ADAMTS2, ADAMTS3, ADAMTS10, ADAMTS14, and ADAMTS17, which 308 encode extracellular proteases that are involved in enzymatic remodeling of the ECM. 309
Two leading SNPs were in LD with potentially damaging missense mutations in 310 ADAMTS10 and ADAMTS17 and two other GWAS signals overlapped with eQTLs 311 for ADAMTS14 and ADAMTS3. In addition, possibly deleterious missense mutations 312 in LD with our leading GWAS SNPs were also found for VCAN and ACAN. Both 313 VCAN and ACAN encode chondroitin sulfate proteoglycan core proteins that 314 constitute structural components of the extracellular matrix, particularly in soft 315 tissues 40 . These proteins also serve as major substrates for ADAMTS proteinases 41 . 316 ECM forms the three-dimensional support structure for connective and soft tissue. In 317 fat tissue, the ECM regulates adipocyte expansion and proliferation 42 . Remodeling of 318 the ECM is required to allow for adipose tissue growth and this is achieved through 319 enzymatic processing of extracellular molecules such as proteoglycans, collagen and 320 hyaluronic acid. For example, ADAMTS2, 3 and 14 act as procollagen N-321 therefore propose that effects of genetic variation in biological systems involved in 323 ECM-remodeling as a factor underlying normal variation in female body fat 324 distribution. 325 326
Conclusions 327
In summary, GWAS of body fat distribution determined by sBIA reveals a genetic 328 architecture that influences distribution of adipose tissue to the arms, legs and trunk. 329
Genetic associations and effects clearly differ between sexes, in particular for 330 distribution of adipose tissue to the legs and trunk. The distribution of body fat in 331 women has been previously been suggested as a causal factor leading to lower risk of 332 cardiovascular and metabolic disease, as well as cardiovascular mortality for women 333 in middle age 5 
Assessing the relationship between adipose tissue ratios and anthropometric traits 415
Phenotypic correlations between fat distribution ratios and anthropometric traits were 416 estimated by calculating semi-partial correlation coefficients for males and females 417 separately , using anova.glm in R. Adipose tissue ratios (AFR, LFR or TFR) were set 418 as the response variable. BMI, waist circumference, waist circumference adjusted for 419 BMI, waist-to-hip ratio, height, or one of the other ratios were included as the last 420 term in a linear model that included, age and principal components as covariates. The 421 reduction in residual deviance, i.e., the reductions in the residual sum of squares as BMI, waist circumference, waist circumference adjusted for BMI, waist-to-hip ratio, 423 height, or one of the other ratios was added to the model, is presented as percentages 424 of the total deviance of the null model in supplementary Table 3 . 425
426
Genome wide association study for body fat ratio 427 A two-stage GWAS was performed using a discovery and a replication cohort. Body 428 fat ratios were adjusted for age, age squared and normalized by rank-transformation 429 separately in males and females using the rntransform function included in the 430 GenABEL library 50 . GWAS was performed in PLINK v1.90b3n 18 using linear 431 regression models with AFR, LFR, and TFR as the response variables and the SNPs 432 as predictor variables. A batch variable was used as covariate in the GWAS for the 433 discovery analyses to adjust for genotyping array (Axiom and BiLEVE). We also 434 included age, the first 15 principal components and sex (in the sex-combined 435 analyses) as covariates in the GWAS. LD score regression intercepts (see further 436 information below), calculated using ldsc 17 , were used to adjust for genomic inflation, 437 by dividing the square of the t-statistic for each tested SNP with the LD-score 438 regression intercept for that GWAS, and then calculating new p-values based on the 439 adjusted t-statistic. We used a threshold of P<10 -7 , after adjusting for LD score 440 intercept, as threshold for significance in the discovery cohort. 441
442
The -clump function in PLINK was used to identify the number of independent 443 signals in each GWAS. This function groups associated SNPs based on the linkage 444 disequilibrium (LD) pattern. The parameters for clumps were set to: -clump-p1 1*10 -445 associations were found in more than one of the three body fat ratios (AFR, TFR, or 448 LFR) or strata (males, females or sex-combined) and different leading SNPs were 449 observed for different traits and strata at several loci. To assess whether these 450 represented the same signal, we assessed the LD between overlapping leading SNPs 451 in PLINK. SNPs in low LD (R 2 -value < 0.05) were considered to represent 452 independent signals. For leading SNPs where we could not exclude that they were in 453 LD (R 2 -value >= 0.05) we performed conditional analysis in PLINK, conditioning on 454 the most significant SNP across all phenotypes and strata. Associations with a P< 455 1*10 -7 after conditioning for the most significant SNP were considered as being 456 independent signals. For each independent signal, the leading SNP (lowest p-value) 457 was taken forward for replication. Meta analyses of results from the discovery and 458 replication cohorts was performed with the METAL software 51 for all independent 459 associations that were taken forward for replication. 460
461

SNP heritability, and genetic correlations 462
We estimated SNP heritability and genetic correlations using LD score regression 463 (LDSC), implemented in the 'ldsc' software package 17 . LDSC uses LD patterns and 464 summary stats from GWAS as input. For genetic correlations, we performed 465 additional sex-stratified GWAS in the UK biobank (using the same covariates as for 466 the ratios) for standard anthropometric traits, BMI, height, WC, WHR, WCadjBMI 467 and WHRadjBMI, in the discovery cohort. GWAS summary stats were filtered for 468 The threshold for significance for the eQTLs was set to 2.3*10 -9 in agreement with 495 previous studies 52 . The strongest associated SNP for each tissue and gene in the GTEx 496 dataset was identified. We then estimated the LD between the top eQTL SNPs and the leading SNPs for each independent association from our analysis. If a SNPs from our 498 analyses were in LD (R 2 > 0.8) with a leading eQTL SNP the two signals were 499 considered overlapping. 500
501
Leading SNPs, and all SNPs in LD (R 2 > 0.8) with a leading SNPs from our analyses 502 (LD determined in the UK biobank cohort in PLINK) were cross-referenced with 503 dbSNP (human 9606 b150) in order to identify potentially deleterious intragenic 504 variants in LD (R 2 > 0.8) with body fat ratio-associated variants. Polyphen and SIFT-505 scores for the missense variants (extracted from Ensembl -www.ensembl.org) were 506 used to assess the deleteriousness of the variants. 507 508
Enrichment analysis 509
To identify the functional roles and tissue specificity of associated variants, we 510 performed tissue and gene-set enrichment analyses using DEPICT 36 . For the gene-set 511 enrichment in DEPICT, gene expression data from 77,840 samples have been used to 512 predict gene function for all genes in the genome based on similarities in gene 513 expression. In comparison to standard enrichment tools that apply a binary definition 514 to define membership in a set of genes that have been associated with a biological 515 pathway or functional category (genes are either included or not included), in 516 DEPICT, the probability of a gene being a member of a gene set has instead been 517 estimated based on correlation in gene expression. This membership probability to 518 each gene set has been estimated for all genes in the human genome and the 519 membership probabilities for each gene have been designated 'reconstituted' gene sets. 520 A total of 14,461 reconstituted gene sets have been generated which represent a wide 521 set of biological annotations (Gene Ontology [GO], KEGG, REACTOME, Mammalian Phenotype [MP], etc.). For tissue enrichment in DEPCIT, microarray 523 data from 37,427 human tissues have been used to identify genes with high 524 expression in different cells and tissues. When performing the tissue enrichment 525 analyses in DEPICT, the most significant GWAS hits are scanned for enrichment of 526 genes that are highly expressed in any cells or tissues. 527 528 For the enrichment analyses, we performed sex-stratified GWAS for AFR, LFR and 529 TFR on a combined set of the UK Biobank cohort, in order to achieve high power for 530 enrichment analyses, including 195,043 females and 167,408 males. The 'clump' 531 functionality in PLINK is used to determine associated loci. The p-value cut off for 532 association for 'clump' was set at P < 10 -7 . In the enrichment analyses, DEPICT 533 assesses whether the reconstituted gene sets are enriched for genes within trait-534 associated loci 36 . The False Discovery Rate (FDR) 53 was used to adjust for multiple 535 testing. Twelve analyses were run in total (tissue enrichment and gene-set 536 enrichment) and FDR<0.05/12 was considered significant. 537 538
Interaction between SNPs and sex 539
We used the GWAMA software 54 to test for heterogenous effects of associated SNPs 540 between sexes. In GWAMA, fixed-effect estimates of sex-specific and sex-combined 541 beta coefficients and standard errors are calculated from GWAS summary statistics to 542 test for heterogeneous allelic effects between females and males. GWAMA obtains a 543 test-statistic by subtracting the sex-combined squared t-statistic from the sum of the 544 two sex-specific squared t-statistics. This test statistic is asymptotically chi-square-545 distributed and equivalent to a normal z-test of the difference in allelic effects 546 between sexes. SNPs that were significant in the replication analyses in any of the strata were tested for heterogeneity between sexes in the replication cohort. 548
Bonferroni correction was used to correct for multiple testing and p-values < 0.05/97 549 were considered to be significant. 550 551 552
Data availability 553
The data that support the findings of this study are available from UK Biobank 554 Reconstituted gene sets found to be enriched for TFR-and LFR-associated genes (in 723 males and females) were compared with results from previous GWAS on 724 Tables   Table 1. Novel body fat ratio-associated loci. Entries represent loci that have not previously been associated with an anthropometric trait.
Locus
Lead γ + -7.21*10 -6 4.40*10 -11 + denotes an observed effect in one of the sexes, i.e. the SNP is associated (p < 1e-7) with one of the body fat ratios in that sex, ++ denotes that the effect was observed to be stronger in one sex when an effect was observed in both sexes. The effects were directionally consistent between sexes in all cases when SNP-effects could be observed in both sexes. The Locus column denotes a gene related to the associated locus either in annotation from previous GWAS( Arg/Gln tolerated benign -possibly damaging *Polyphen-2 32 and SIFT 31 scores were extracted from Ensembl (www.ensembl.org). SIFT utilizes protein sequence data to predict the effects of a missense variant while Polyphen-2 also considers protein structure and evolutionary conservation. Polyphen-2 generates a probability that a missense mutation is damaging, while SIFT generates a probability that the amino acid change is tolerated. Polyphen-2 uses a tree-tiered prediction score: 0-0.15 is predicted to be benign, 0.15 to 0.85 possibly damaging and 0.85 -1.0 more confidently predicted to be damaging (i.e., probably damaging). A SIFT score < 0.05 is predicted to be deleterious 31 . Polyphen-2 and SIFT scores are presented as ranges in the cases where they differ due to being part of different transcript variants. 
